Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 13  •  09:35AM ET
24.94
Dollar change
+0.11
Percentage change
0.44
%
Category
US Equities - Industry Sector
Asset Type
Equities (Stocks)
Tags
Return% 1Y
15.87%
Total Holdings
71
Perf Week
0.72%
Sponsor
Fidelity
ETF Type
Tags
Return% 3Y
-
AUM
57.81M
Perf Month
2.30%
Fund Family
Bond Type
Tags
Return% 5Y
-
NAV/sh
Perf Quarter
-10.25%
Index
-
Average Maturity
Tags
Return% 10Y
52W High
29.07 -14.21%
Perf Half Y
-3.91%
Index Weighting
Commodity Type
Tags
Return% SI
52W Low
22.00 13.36%
Perf YTD
-7.80%
Active/Passive
Quant Type
Tags
Flows% 1M
0.00%
Volatility
1.44% 1.33%
Perf Year
9.67%
ESG Type
Tags
-
Flows% 3M
0.00%
ATR (14)
0.44
Perf 3Y
-
Dividend Type
Sector/Theme
Flows% YTD
0.00%
RSI (14)
51.34
Perf 5Y
-
Structure Type
Region
Flows% 1Y
Beta
0.98
Perf 10Y
-
Expense
0.50%
Growth/Value
SMA20
1.90%
Flows% 3Y
Rel Volume
2.33
Prev Close
24.83
Inverse/Leveraged
Market Cap
SMA50
-1.21%
Flows% 5Y
Avg Volume
6.64K
Price
24.94
IPO
Jun 12, 2023
Option/Short
Yes / Yes
SMA200
-2.70%
Trades
Volume
964
Change
0.44%
Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.